Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 12035

AbstractConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Reviews
Year : 2026 | Month : September | Volume : 20 | Issue : 9 | Page : LE11 - LE17 Full Version

Kyasanur Forest Disease: A Narrative Review of Clinical Features, Transmission, Diagnosis and Public Health Strategies


Published: September 1, 2026 | DOI: https://doi.org/10.7860/JCDR/2026/85541.24412
Amartya Aaruhya, Anupama Sawal, Bhagyesh Sapkale

1. Undergraduate Student, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India. 2. Professor, Department of Anatomy, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India. 3. Undergraduate Student, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.

Correspondence Address :
Amartya Aaruhya,
Undergraduate Student, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha-442107, Maharashtra, India.
E-mail: amartya.104@gmail.com

Abstract

Kyasanur Forest Disease (KFD) is an emerging tick-borne viral haemorrhagic illness which is endemic to the Western Ghats of southern India, caused by the Kyasanur Forest Disease Virus (KFDV), a Flavivirus transmitted primarily by haemaphysalis ticks. KFD presents after a 3-8 day incubation with abrupt fever, headache, myalgia and gastrointestinal symptoms and may progress to haemorrhagic and neurological complications. Spread of KFD to other neighbouring states underscores challenges to control the disease. Diagnosis of KFD depends upon Reverse Transcription Polymerase Chain Reaction (RT-PCR) during early viremia, which is then followed by Immunoglobulin M (IgM) Enzyme-Linked Immunosorbent Assay (ELISA), with emerging isothermal amplification techniques showing promise for field use. Measures for prevention of KFD are vaccination, carcass disposal, avoidance of ticks, along with community education. Treatment is mainly supportive, which focuses on intensive care for severe cases. Strengthening of surveillance methods, vaccinations and integrated one health strategies are essential for reducing burden of the disease.

Keywords

Arboviral infections, Disease surveillance, Flavivirus, Haemorrhagic fever, Tick-borne diseases

Kyasanur Forest Disease (KFD) is a tick-borne zoonotic illness which is caused by KFDV, a member of the genus Flavivirus (1),(2). Humans are infected primarily through bites of infected hard ticks (notably Haemaphysalis spinigera) and the clinical spectrum ranges from an acute febrile illness with myalgia, headache and haemorrhagic manifestations to neurological complications in a subset of patients (2),(3). The disease has been classically associated with the Western Ghats of southern India and remains focal to forest-fringe communities and people who enter endemic forested areas, where enzootic transmission cycles between ticks and mammalian hosts maintain the virus (4).

The KFD was first recognised in March 1957 following an epizootic of sudden deaths among monkeys and a cluster of severe febrile illness in humans in the Kyasanur forest range (Shimoga district), Karnataka; subsequent virological investigations isolated a novel virus that was shown to be related to the Russian spring-summer encephalitis complex (5),(6). Over the ensuing decades the disease has persisted in the Western Ghats and particularly in the last 15-20 years has been reported outside the original district into adjoining states (Kerala, Goa, Maharashtra and Tamil Nadu), highlighting both ecological change and gaps in control measures (7). Control efforts have included an inactivated tissue-culture vaccine and tick-avoidance strategies, but recurring outbreaks, variable vaccine uptake/effectiveness and expanding geographic reports underscore ongoing public-health challenges (8),(9).

Search Methodology

The present narrative review was developed through a comprehensive search of electronic databases which was inclusive of PubMed, Scopus, Web of Science and Google Scholar. Relevant literature which was published up to January 2026 was identified using combinations of keywords like KFD, tick-borne flavivirus, clinical features, pathogenesis, diagnosis, RT-PCR, vaccination, public health and one health approach. Peer-reviewed original research articles, review articles, surveillance reports, outbreak investigations and publications from recognised public health agencies were also considered. Additional relevant studies were identified through manual screening of reference lists of selected articles. Articles were selected based upon their relevance to scope of the present review with emphasis on recent advances in clinical presentation, laboratory diagnosis, prevention strategies as well as public health interventions related to KFD.

Clinical Features of Kyasanur Forest Disease (KFD)

The KFD typically begins after an incubation period of almost 3-8 days with a sudden, influenza-like febrile illness (10). Early symptoms in such cases are high fever along with having severe frontal headache, which is further marked by myalgia and prostration, chills and often nausea, vomiting with other gastrointestinal complaints (11),(12). Conjunctival infection and photophobia are also frequently reported in patients suffering with KFD (11). KFD is classically described as biphasic in a subset of patients an acute viremic phase followed, in few of the cases, by a second “toxic” phase with new or worsening symptoms (8),(13),(14).

Haemorrhagic manifestations (epistaxis, haematemesis, melena and other bleeding) were prominent in early descriptions of KFD and it still remains an important aspect of severe presentation in few cases (14),(15). Neurological involvement is also increasingly recognised which may occur in either phase presenting as altered sensorium, seizures, focal deficits, aseptic meningitis or postinfectious cerebellitis (16). Other severe complications in cases of KFD are circulatory shock, myocarditis, acute respiratory distress and hyperinflammatory syndromes (for example, haemophagocytic lymphohistiocytosis) in only few selected patients (8),(17). Clinical features and complications of KFD are briefed in (Table/Fig 1) (8),(10),(11),(12),(13),(14),(15),(16),(17),(18).

Aetiology and Pathogenesis of Kyasanur Forest Disease (KFD)

The KFD is caused by KFDV which is a zoonotic, tick-borne pathogen: humans are incidental hosts who typically acquire infection following the bite of infected hard ticks (primarily Haemaphysalis spp.), whereas non human primates (especially macaques) and various small mammals act as amplifying hosts in enzootic cycles (18). Transmission of KFD is complex and supports both horizontal and vertical maintenance of the virus in populations of ticks (19). KFDV is detected during various field and molecular studies in multiple Haemaphysalis species and importantly have provided direct evidence of transovarial (female tick ? eggs ? larvae) transmission, which further helps explain how KFDV persists in nature across seasons and in locations where mammalian hosts are intermittently available (2),(19),(20). Human infection therefore often clusters in forested or peri-forested settings with high tick exposure (20).

Pathogenesis of KFD in humans begins with a short incubation period which is later followed by high viremia during the first week of illness; viral RNA is detectable in blood and, in some patients, in throat swabs and urine, aligning with the systemic spread seen in severe cases (18),(21). KFDV is pantropic but shows neurotropism in severe or late disease, inducing apoptosis in neurons of cerebrum and hippocampus in animal models and contributing to the neurological manifestations reported clinically (13),(22). Host innate and adaptive immune responses which include strong pro-inflammatory signalling are observed in infected cells which thereby mediate both viral clearance and immunopathology, thus together produce febrile, haemorrhagic and occasional neurologic phenotype of KFD (8),(23). Pathogenesis of KFD is depicted through (Table/Fig 2).

Host Immune Responses to Kyasanur Forest Disease Virus (KFDV)

Host immune responses play an important role into determination of severity and outcome of KFDV infection (24). Following viral entry, the innate immune system is activated through pattern recognition receptors which detect viral RNA resulting into induction of interferon-mediated antiviral responses as well as production of pro-inflammatory cytokines (25). KFDV infection also stimulates cytokines such as tumour necrosis factor-α, interleukin-6 and interferon-γ which contribute into viral clearance but it can also drive systemic inflammation associated with severe disease manifestations (24),(25). Adaptive immune responses further contribute into host defense usually through generation of neutralising antibodies directed against viral envelope proteins which limit viral replication which provides protective immunity following natural infection or vaccination (24),(26). In addition, T-cell mediated immune responses are believed to support viral control through cytotoxic activity, cytokine signalling although excessive immune activation can further contribute into immunopathological effects observed in severe cases of KFD (26).

Phylogenetic and Sequence Similarity Insights into KFD Virus

Genomic sequencing as well as phylogenetic studies helped to provide insights into the dynamics of KFDV in the Indian regions (27). Comparative analyses of viral isolates collected over several decades have also showed remarkably low genetic diversity among KFDV strains thereby suggesting that virus has remained genetically stable since its initial identification (27). Whole-genome phylogenetic investigations analysing isolates from 1957 to recent year outbreaks have showed only minimal nucleotide divergence (approximately 1-2%) among strains thereby indicating slow evolutionary change as compared to many other types of Ribonucleic Acid (RNA) viruses (27),(28). Such genetic stability can thus partly explain persistence of similar clinical as well as epidemiological characteristics of KFD across successive outbreaks in endemic regions of Western Ghats (27).

More recent phylogeographic analyses which is done using genome sequencing of isolates from newly affected regions have provided evidence of regional lineage diversification associated with geographic spread of the virus (27). Viral strains which are detected in areas like Kerala, Goa and Maharashtra cluster closely along with earlier Karnataka strains thus supporting hypothesis that emergence of KFD in these locations represents geographic expansion rather than emergence of genetically distinct variants (27),(29),(30). Sequence analyses of structural genes particularly envelope glycoprotein gene have also showed very high sequence similarity (>99%) between historical as well as contemporary isolates suggesting that antigenic determinants remain largely conserved (31). All these findings highlight about importance of continued genomic surveillance for monitoring viral evolution to assess whether emerging mutations can influence transmission dynamics, virulence as well as effectiveness of vaccines in endemic regions of KFD (27),(31).

Seasonal Fluctuations of Kyasanur Forest Disease (KFD)

The KFD shows a marked seasonal pattern which is closely linked having ecological dynamics of its tick vectors as well as climatic conditions in Western Ghats (32). Human cases usually occur during dry season from November to May along with a peak incidence between January and March corresponding to period of heightened activity of the nymphal stage of Haemaphysalis ticks (32). These nymphs are highly anthropophilic which further readily attach to humans when they enter forested environments for activities such as agriculture, firewood collection, grazing livestock (32). Increased human-forest interaction during this season enhances risk of exposure to infected ticks as well as it facilitates spillover of the virus from wildlife reservoirs to human beings (32).

The seasonal dynamics of KFD are influenced by climatic factors usually rainfall and temperature which regulate tick population density and survival (29),(32). Endemic region studies such as Shivamogga (Karnataka), Wayanad (Kerala) and Goa have showed that transmission of KFD begins soon after cessation of monsoon in cases when environmental conditions favor proliferation of host-seeking nymphal ticks (29),(33). During monsoon period (which is June-October months), heavy precipitation suppresses tick activity also it further interrupts transmission cycles (33). Conversely, post-monsoon period is usually characterised by moderate temperatures, reduced rainfall (<500 mm cumulative precipitation) which creates optimal conditions for survival of ticks as well as an increased risk for human exposure (33). All these climatic correlations highlight about important role of environmental factors into shaping of seasonal epidemiology of KFD (33).

In addition to climatic determinants, life cycle of the vector ticks also contributes into seasonal pattern of KFD transmission (34). After the monsoon season; larval ticks emerge which further feed on small mammals and birds subsequently moulting into nymphs which become highly active during winter as well as early summer months (34),(35). This stage is usually significant because nymphs have broader host range frequently infest humans thereby acting as principal stage responsible for transmission of KFD virus (34). Studies which focus on tick ecology in endemic areas have showed that density of questing nymphal ticks increases substantially from December to February paralleling rise in human cases during same time period (34),(35). Understanding all these seasonal fluctuations is an essential aspect for timely planning preventive interventions inclusive of vaccination campaigns before the transmission season, intensified tick surveillance, community awareness programmes and early warning systems based on ecological indicators such as monkey deaths (35).

Emerging Diagnosis of Kyasanur Forest Disease (KFD)

Diagnosis of KFD mainly depends upon combination of clinical suspicion in the appropriate epidemiological setting and laboratory confirmation (36). During the early (viremic) phase, detection of KFD viral RNA by Reverse-Transcription PCR (RT-PCR) from acute-phase blood (serum or plasma) is the diagnostic method of choice because it directly demonstrates the virus and gives the highest sensitivity early on (36),(37). Laboratory-based real-time RT-PCR and nested RT-PCR assays are developed for NS5/non coding regions which are widely used in reference laboratories and were shown to identify cases that serology alone would miss in the acute period of KFD (38).

Serology becomes useful later in illness: anti-KFDV Immunoglobulin M (IgM) {capture Enzyme-Linked Immunosorbent Assay (ELISA)} usually appears after the viremic phase and is employed for diagnosis from about day 5-7 onward or on convalescent sera; paired acute and convalescent phase sera can thereby confirm recent infection when PCR is negative (39). Routine isolation of virus is possible but is slow and requires high-containment facilities, so it is rarely used for rapid diagnosis of case scenario (39). Cross-reactivity with other flaviviruses also can affect some serological assays, so interpretation must consider clinical timeline of disease along with local arboviral epidemiology (40). Due to occurrence of KFD in remote, forested areas, recent work has focused on bringing diagnostics closer to the field: validated point-of-care molecular platforms (for example, Truenat KFD) and simplified isothermal/dry-down RNA detection methods have shown promise for faster, decentralised testing with reasonable agreement to laboratory RT-PCR (40),(41).

Emerging diagnostic innovations for KFD include Reverse Transcription-Polymerase Spiral Reaction (RT-PSR) combined with magnetic bead-based RNA extraction in a dry-down format (42). This portable and equipment-light method performs isothermal amplification at 63°C for about 60 minutes, detecting as few as 10 viral RNA copies per reaction (42). Results are visually interpreted using colour change via Hydroxy Naphthol Blue dye (42). Its performance and lack of cross-reactivity with other similar flaviviruses make it promising to be used in low-resource, field-based settings (42).

Reverse-Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) assay can be used for detection of KFDV (43). In this method viral RNA is amplified at a constant temperature in one step (60 min at 63°C) and has a detection limit of just 10 copies (43). Evaluated across human, primate and tick samples, RT-LAMP demonstrated 100% concordance with conventional TaqMan qRT-PCR and showed high specificity with no cross-reactivity to other haemorrhagic/flaviviruses (43),(44). All these makes RT-LAMP, an ideal for rapid, high-throughput screening during outbreaks, especially where laboratory infrastructure is minimal (43). Diagnostic methods for KFD are depicted in (Table/Fig 3) (36),(37),(39),(40),(41),(42),(43),(44).

Differential Diagnosis of Kyasanur Forest Disease (KFD)

The KFD shares several clinical features along with other acute febrile illnesses endemic to tropical regions particularly dengue, leptospirosis and malaria, which often complicates early clinical diagnosis (14). Patients having KFD usually present with abrupt onset of high fever, severe headache, myalgia, gastrointestinal symptoms and thrombocytopenia features which significantly overlap with those observed in dengue and other viral haemorrhagic fevers (14),(45). In dengue infection, however, patients usually show retro-orbital pain, rash and marked haemoconcentration due to plasma leakage which are less commonly observed in KFD (45). Similarly, haemorrhagic manifestations can occur in both diseases but KFD often shows a biphasic illness pattern which may progress to neurological complications such as meningitis or encephalitis in the later stage which are less usual in uncomplicated-type of dengue infection (14). Laboratory confirmation which is done using molecular assays inclusive of RT-PCR, virus-specific serological testing are essential for distinguishing KFD from similar arboviral infections in endemic areas (41).

Leptospirosis and malaria are also important considerations in differential diagnosis of KFD because they usually present with acute febrile illness which is accompanied by headache, myalgia and systemic involvement (46). Leptospirosis can also mimic KFD having symptoms such as fever, myalgia and conjunctival suffusion. However severe cases often show jaundice, renal impairment and pulmonary haemorrhage which are not characteristic findings in KFD (46),(47). Malaria, usually caused by Plasmodium falciparum can present with fever, thrombocytopenia along with systemic complications that resemble early KFD, but periodic fever patterns, splenomegaly as well as detection of parasites on peripheral blood smear or rapid antigen tests aid in differentiation (48). Epidemiological history is very crucial aspect in distinguishing these infections; exposure to forested areas having known tick activity as well as reports of monkey deaths are strong epidemiological indicators suggestive of KFD (47). Therefore, integration of clinical presentation, exposure history and confirmatory laboratory investigations is also critical for accurate diagnosis as well as appropriate management in endemic regions (47). The differential diagnoses of KFD are summarised in (Table/Fig 4) (14),(41),(45),(46),(47),(48).

Vaccination and Community-Based Interventions for Prevention of KFD

Vaccination has traditionally used as a preventive strategy against KFD (49). Field studies which are conducted in endemic districts of Karnataka have demonstrated that inactivated KFD vaccine provides moderate protection when administered before transmission season usually when the recommended primary doses, booster schedules are completed (14),(30). Observational studies have further suggested about effectiveness of vaccine which improves with timely booster doses as well as adequate coverage in high-risk populations inclusive of forest workers and tribal communities residing in endemic regions (35),(50). However, challenges such as incomplete vaccination schedules, delayed booster administration as well as logistical barriers in remote forest areas have been reported for reducing overall protective impact of vaccination program (35),(47). The formalin-inactivated vaccine also offers effectiveness with two doses and have more effectiveness with an additional third dose (49).

During 2022 outbreak of KFD in Shivamogga, Karnataka, it was found that no statistically significant difference is there in disease incidence between vaccinated and unvaccinated individuals (30). These observations suggest that vaccine coverage, timing, matching of strain, logistical challenges, or waning immunity can further undermine protective benefits, thus it highlights an urgent need to revisit vaccination strategies and improving surveillance of vaccine effectiveness (30),(49).

Complementing efforts of immunisation, environmental and community-based interventions have vital roles in disease prevention (30). The study from Shivamogga emphasised the importance of timely and safe disposal of monkey carcasses, since dead monkeys may harbour infected ticks which can further pose an indirect risk to nearby populations (30). Additionally, targeted behaviour change communication like wearing full-body, light-coloured clothing, using tick repellents such as Dimethylphthalate (DMP)/N -Diethyl Phenylacetamide (DEPA) oil, conducting self-checks for ticks after exposure to forest area and avoiding areas with recent deaths of monkey is essential in endemic communities (51),(52). Integrating all these practices with active surveillance, rapid monkey necropsy and community education especially in vulnerable tribal populations relying on forests supports a multidisciplinary One Health approach to mitigate risk of having KFD (52),(53).

Management of Kyasanur Forest Disease (KFD)

Treatment of KFD is currently mainly supportive and symptomatic because there is no proven, specific antiviral therapy (54). Early care focuses on fluid balance, antipyretics, analgesia, close monitoring of haemodynamic status, blood counts and prompt management of bleeding (55). Supportive care protocols also emphasise about regular monitoring of platelet counts, liver enzymes and renal parameters as haematological abnormalities such as thrombocytopenia, leukopenia are usually observed during acute phase of illness (17),(40). Careful assessment of hydration status as well as maintenance of electrolyte balance are important for prevention of complications associated having systemic inflammatory responses and gastrointestinal symptoms (40). In endemic regions, early hospitalisation, close observation during first week of illness are usually recommended for promptly identifying progression to severe KFD disease in patients (14),(40). Routine broad-spectrum antibiotics are not indicated unless a secondary bacterial infection is suspected in such cases; most uncomplicated patients improve with conservative in-patient care and observation (14).

Targeted supportive interventions along with intensive monitoring for haemorrhagic complications, correction of coagulopathy and intensive-care management for respiratory failure or shock are required in severe cases of KFD (8),(33). Patients having severe manifestations such as circulatory shock, significant haemorrhage, neurological complications can require admission to intensive care units for advanced supportive management of KFD (23),(56),(57). Critical care measures are inclusive of haemodynamic stabilisation, blood product transfusion for severe bleeding, ventilatory support in cases of respiratory distress as well as close neurological monitoring (57). Early recognition of complications, timely escalation of care has been reported for improvement of clinical outcomes in hospitalised patients having severe KFD (18),(57). Neurological involvement in KFD further requires early Intensive Care Unit (ICU) care, seizure control and neurocritical support; adjunctive immunomodulatory therapies such as corticosteroids (23),(56). Research must be carried out on broad-spectrum antivirals and immunotherapies, but at present clinical management remains supportive (56).

The overall case fatality rate of KFD has been reported to range in between 3% and 5% in most outbreaks although outcomes vary depending on severity of disease as well as access to timely medical care (58). Most patients having uncomplicated illness recover completely with supportive treatment whereas severe cases presenting with neurological involvement, haemorrhagic complications can further require prolonged hospitalisation, intensive monitoring (33),(58). Strengthening of early detection, supportive management protocols thereby remains an essential aspect into improving patient outcomes in endemic regions of KFD cases (2),(21).

Repurposed and Investigational Therapeutic Approaches

Due to the absence of a specific antiviral therapy for KFDV; recent research articles have further explored potential usage of repurposed antiviral drugs which helps targeting conserved flaviviral replication pathways (59). Broad-spectrum antiviral agents which are inclusive of ribavirin which has shown inhibitory activity against several RNA viruses have been evaluated experimentally for their possible utility against KFDV and related tick-borne flaviviruses, although convincing clinical evidence still remains limited [18,59]. Additionally, studies investigating about antiviral compounds targeting viral RNA-dependent RNA polymerase as well as other replication-associated proteins have suggested that drugs originally developed for other viral infections can interfere with flaviviral replication (14),(60). High-throughput screening of existing drug libraries further identified several small-molecule inhibitors having activity against related flaviviruses thus highlighting about potential of drug repurposing strategies in identification of candidate therapeutics (61). All these approaches remain largely experimental, continued research on repurposed antivirals as well as host-targeted therapies can provide promising directions for development of effective treatments for severe cases of KFD (14),(61).

Conclusion

The KFD remains an important public health challenge in India, particularly in forest living communities of the Western Ghats.Despite advances in diagnosis methods, vaccination strategies, preventive options, recurrent outbreaks and geographic spread highlight gaps in control measures. Supportive care remains the main aspect of management, as no specific antiviral exists. Enhancing disease surveillance, improving vaccine effectiveness and implementing integrated tick-control strategies alongside community-based interventions are crucial for effective disease control. A coordinated One Health approach is thus, essential for reducing disease burden to mitigate future outbreaks in endemic and emerging regions.

Authors contribution: The AA contributed to the conceptualisation, literature review, data collection and drafting of the manuscript. AS provided supervision, critically revised the manuscript for important intellectual content and approved the final version. BS contributed to literature review, data interpretation, manuscript drafting and formatting of tables and figures. All authors read and approved the final manuscript.

References

1.
Ghosh S, Nagar G. Problem of ticks and tick-borne diseases in India with special emphasis on progress in tick control research: A review. J Vector Borne Dis. 2014 Dec;51(4):259-70. PubMed PMID: 25540956.[crossref] [PubMed]
2.
Srilekha N, Venkataramana K, Sriram G, Jayashankar C, Harshitha A, Akshay A, et al. Kyasanur forest disease: A comprehensive review. Cureus. 2024;16(7):e65228. Doi: 10.7759/cureus.65228 PubMed PMID: 39184677; PubMed Central PMCID: PMC11343324.
3.
Muraleedharan M. Kyasanur Forest Disease (KFD): Rare Disease of Zoonotic Origin. J Nepal Health Res Counc. 2016;14(34):214-218. Doi: 10.33314/jnhrc.v14i3.881. PMID: 28327690.
4.
Rodriguez-Morales AJ, Ramirez-Jaramillo V, Sánchez-Carmona D, Gil-Restrepo AF, Cardona-Ospina JA, Paniz-Mondolfi A. Kyasanur forest disease: Another flavivirus requiring more research? Results of a bibliometric assessment. Travel Med Infect Dis. 2017;19:68-70. Doi: 10.1016/j.tmaid.2017.08.004 PubMed PMID: 28843350.[crossref] [PubMed]
5.
Chakraborty S, Andrade FCD, Ghosh S, Uelmen J, Ruiz MO. Historical expansion of kyasanur forest disease in India from 1957 to 2017: A retrospective analysis. GeoHealth. 2019;3(2):44-55. Doi: 10.1029/2018GH000164 PubMed PMID: 32159030; PubMed Central PMCID: PMC7007137.[crossref] [PubMed]
6.
Negi T, Kandari LS, Arunachalam K. Update on prevalence and distribution pattern of tick-borne diseases among humans in India: A review. Parasitol Res. 2021;120(5):1523-39. Doi: 10.1007/s00436-021-07114-x PubMed PMID: 33797610.[crossref] [PubMed]
7.
Holbrook MR. Kyasanur forest disease. Antiviral Res. 2012;96(3):353-62. Doi: 10.1016/j.antiviral.2012.10.005 PubMed PMID: 23110991; PubMed Central PMCID: PMC3513490.[crossref] [PubMed]
8.
Gladson V, Mathew S, Benny J, Aayilliath KA, Kumar PJ, Rajasi RS. A case series on the spectrum of complications observed in Kyasanur forest disease. Cureus. 2024;16(5):e59971. Doi: 10.7759/cureus.59971 PubMed PMID: 38854314; PubMed Central PMCID: PMC11162157.[crossref] [PubMed]
9.
Sebastian AP, Varma M, Gupta N. Kyasanur forest disease in India: A case report. J Travel Med. 2024;31(5):taae071. Doi: 10.1093/jtm/taae071 PubMed PMID: 38753838.[crossref] [PubMed]
10.
Mackenzie JS, Williams DT. The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: The potential for emergent viruses. Zoonoses Public Health. 2009;56(6-7):338-56. Doi: 10.1111/j.1863-2378.2008.01208.x PubMed PMID: 19486319.[crossref] [PubMed]
11.
Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018;148(2):145-50. Doi: 10.4103/ijmr.IJMR_688_17 PubMed PMID: 30381537; PubMed Central PMCID: PMC6206778.[crossref] [PubMed]
12.
Ghosh S, Azhahianambi P, Yadav MP. Upcoming and future strategies of tick control: A review. J Vector Borne Dis. 2007;44(2):79-89. PubMed PMID: 17722860.
13.
Swathikiran PV, Gupta N, Varma M, Mukhopdhyay C. Neurological involvement in two phases of Kyasanur Forest Disease. Indian J Med Microbiol. 2025;56:100901. Doi: 10.1016/j.ijmmb.2025.100901 PubMed PMID: 40544961.[crossref] [PubMed]
14.
Gupta N, Wilson W, Neumayr A, Saravu K. Kyasanur forest disease: A state-of-the-art review. QJM Mon J Assoc Physicians. 2022;115(6):351-58. Doi: 10.1093/qjmed/hcaa310 PubMed PMID: 33196834.[crossref] [PubMed]
15.
Devadiga S, Arunkumar G. Kinetics of human infection with Kyasanur Forest Disease Virus. J Infect. 2022;85(2):161-66. Doi: 10.1016/j.jinf.2022.05.020 PubMed PMID: 35609707.[crossref] [PubMed]
16.
Gupta N, Malapure SS, Kiran PVS, Sebastian A, Varma M, Mukhopadhyay C, et al. Kyasanur forest disease cerebellitis. J Travel Med. 2025;taaf080. Doi: 10.1093/jtm/taaf080 PubMed PMID: 40748312.[crossref] [PubMed]
17.
Gupta N, Chunduru K, Safeer KM, Saravu K. Clinical and laboratory profile of patients with Kyasanur forest disease: A single-centre study of 192 patients from Karnataka, India. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2021;135:104735. Doi: 10.1016/j.jcv.2021.104735 PubMed PMID: 33493988.[crossref] [PubMed]
18.
Shah SZ, Jabbar B, Ahmed N, Rehman A, Nasir H, Nadeem S, et al. Epidemiology, pathogenesis, and control of a tick-borne disease- kyasanur forest disease: Current status and future directions. Front Cell Infect Microbiol. 2018;8:149. Doi: 10.3389/fcimb.2018.00149 PubMed PMID: 29868505; PubMed Central PMCID: PMC5954086.[crossref] [PubMed]
19.
Murhekar MV, Kasabi GS, Mehendale SM, Mourya DT, Yadav PD, Tandale BV. On the transmission pattern of Kyasanur Forest disease (KFD) in India. Infect Dis Poverty. 2015;4:37. Doi: 10.1186/s40249-015-0066-9 PubMed PMID: 26286631; PubMed Central PMCID: PMC4545326.[crossref] [PubMed]
20.
Shah T, Li Q, Wang B, Baloch Z, Xia X. Geographical distribution and pathogenesis of ticks and tick-borne viral diseases. Front Microbiol. 2023;14:1185829. Doi: 10.3389/fmicb.2023.1185829 PubMed PMID: 37293222; PubMed Central PMCID: PMC10244671.[crossref] [PubMed]
21.
Ajesh K, Nagaraja BK, Sreejith K. Kyasanur forest disease virus breaking the endemic barrier: An investigation into ecological effects on disease emergence and future outlook. Zoonoses Public Health. 2017;64(7):e73-e80. Doi: 10.1111/zph.12349 PubMed PMID: 28220635.[crossref] [PubMed]
22.
Nikiforuk AM, Tierny K, Cutts TA, Kobasa DK, Theriault SS, Cook BWM. Kyasanur Forest disease virus non-mouse animal models: A pilot study. BMC Res Notes. 2020;13(1):291. Doi: 10.1186/s13104-020-05137-8 PubMed PMID: 32539799; PubMed Central PMCID: PMC7296627.[crossref] [PubMed]
23.
Gupta N, Nallapati VT, Chunduru K, Vithivattical ARJ, Kadavigere R, Saravu K. Neurological manifestations of Kyasanur Forest disease: A retrospective cohort study from South India. Trans R Soc Trop Med Hyg. 2022;116(10):944-48. Doi: 10.1093/trstmh/trac018 PubMed PMID: 35355076.[crossref] [PubMed]
24.
N NB, Gupta N, Pattanaik A, Mukhopadhyay C, Devadiga S. Temporal dynamics of the immune response in severe cases of human Kyasanur Forest Disease Virus (KFDV) infection. J Med Virol. 2025;97(11):e70697. Doi: 10.1002/jmv.70697 PubMed PMID: 41217250.[crossref] [PubMed]
25.
Kaushal H, Kumar Meena V, Das S, Sarkar S, Kartaskar RS, Sharma V, et al. Pathogenicity and virulence of Kyasanur Forest disease: A comprehensive review of an expanding zoonotic threat in southwestern India. Virulence. 2025;16(1):2580154. Doi: 10.1080/21505594.2025.2580154 PubMed PMID: 41165010; PubMed Central PMCID: PMC12578315.[crossref] [PubMed]
26.
Devadiga S, McElroy AK, Prabhu SG, Arunkumar G. Dynamics of human B and T cell adaptive immune responses to Kyasanur Forest disease virus infection. Sci Rep. 2020;10(1):15306. Doi: 10.1038/s41598-020-72205-1 PubMed PMID: 32943687; PubMed Central PMCID: PMC7499197.[crossref] [PubMed]
27.
Yadav PD, Patil S, Jadhav SM, Nyayanit DA, Kumar V, Jain S, et al. Phylogeography of Kyasanur Forest Disease virus in India (1957-2017) reveals evolution and spread in the Western Ghats region. Sci Rep. 2020;10(1):1966. Doi: 10.1038/s41598-020-58242-w PubMed PMID: 32029759; PubMed Central PMCID: PMC7005018.[crossref] [PubMed]
28.
Zhang C, Li Y, Samad A, He H, Ma H, Chen Y, et al. Kyasanur Forest disease virus NS3 helicase: Insights into structure, activity, and inhibitors. Int J Biol Macromol. 2024;254(Pt 3):127856. Doi: 10.1016/j.ijbiomac.2023.127856 PubMed PMID: 37924898.[crossref] [PubMed]
29.
Oliveira A, Selvaraj K, Tripathy JP, Betodkar U, Cacodcar J, Quadros N, et al. Geospatial clustering, seasonal trend and forecasting of Kyasanur Forest Disease in the state of Goa, India, 2015-2018. Trop Med Health. 2020;48:27. Doi: 10.1186/s41182-020-00213-y PubMed PMID: 32355449; PubMed Central PMCID: PMC7187534.[crossref] [PubMed]
30.
Vedachalam SK, Rajput BL, Choudhary S, Narayanaswamy D, Chandra S, D M P, et al. Kyasanur forest disease: An epidemiological investigation and case-control study in Shivamogga, Karnataka, India-2022. Int J Public Health. 2024;69:1606715. Doi: 10.3389/ijph.2024.1606715 PubMed PMID: 39494093; PubMed Central PMCID: PMC11527609.[crossref] [PubMed]
31.
Shil P, Yadav PD, Patil AA, Balasubramanian R, Mourya DT. Bioinformatics characterization of envelope glycoprotein from Kyasanur Forest disease virus. Indian J Med Res. 2018;147(2):195-201. Doi: 10.4103/ijmr.IJMR_1445_16 PubMed PMID: 29806609; PubMed Central PMCID: PMC5991130.[crossref] [PubMed]
32.
Naren Babu N, Jayaram A, Hemanth Kumar H, Pareet P, Pattanaik S, Auti AM, et al. Spatial distribution of Haemaphysalis species ticks and human Kyasanur Forest Disease cases along the Western Ghats of India, 2017-2018. Exp Appl Acarol. 2019;77(3):435-47. Doi: 10.1007/s10493-019-00345-9 PubMed PMID: 30809731.[crossref] [PubMed]
33.
Singh P, Kumar P, Dhiman RC. Kyasanur forest disease and climatic attributes in India. J Vector Borne Dis. 2022;59(1):79-85. Doi: 10.4103/0972-9062.331408 PubMed PMID: 35708408.[crossref] [PubMed]
34.
Balasubramanian R, Yadav PD, Sahina S, Arathy Nadh V. Distribution and prevalence of ticks on livestock population in endemic area of Kyasanur forest disease in Western Ghats of Kerala, South India. J Parasit Dis Off Organ Indian Soc Parasitol. 2019;43(2):256-62. Doi: 10.1007/s12639-019-01086-7 PubMed PMID: 31263331; PubMed Central PMCID: PMC6570721.[crossref] [PubMed]
35.
Balasubramanian R, Yadav PD, Sahina S, Nadh VA. The species distribution of ticks & the prevalence of Kyasanur forest disease virus in questing nymphal ticks from Western Ghats of Kerala, South India. Indian J Med Res. 2021;154(5):743-49. Doi: 10.4103/ijmr.IJMR_234_19 PubMed PMID: 35532592; PubMed Central PMCID: PMC9210533.[crossref] [PubMed]
36.
Gupta N, Boodman C, Saravu K. Development of a clinical scoring system to make a presumptive diagnosis of Kyasanur Forest Disease: A case-control study from South India. Infez Med. 2024;32(1):61-68. Doi: 10.53854/liim-3201-8 PubMed PMID: 38456026; PubMed Central PMCID: PMC10917564.[crossref]
37.
Chaubal G, Sarkale P, Kore P, Yadav P. Development of single step RT-PCR for detection of Kyasanur forest disease virus from clinical samples. Heliyon. 2018;4(2):e00549. Doi: 10.1016/j.heliyon.2018.e00549 PubMed PMID: 29560461; PubMed Central PMCID: PMC5857640.[crossref] [PubMed]
38.
Sudheesh N, Hewson R, Afrough B, Bewley K, Arunkumar G. Development of a quantitative real-time RT-PCR assay that differentiates between Kyasanur Forest disease virus and Alkhurma hemorrhagic fever virus. Ticks Tick-Borne Dis. 2020;11(3):101381. Doi: 10.1016/j.ttbdis.2020.101381 PubMed PMID: 32009000.[crossref] [PubMed]
39.
Mourya DT, Yadav PD, Mehla R, Barde PV, Yergolkar PN, Kumar SRP, et al. Diagnosis of Kyasanur forest disease by nested RT-PCR, real-time RT-PCR and IgM capture ELISA. J Virol Methods. 2012;186(1–2):49-54. Doi: 10.1016/j.jviromet.2012.07.019 PubMed PMID: 22874757.[crossref] [PubMed]
40.
Gladson V, Moosan H, Mathew S, Dineesh P. Clinical and laboratory diagnostic features of kyasanur forest disease: A study from Wayanad, South India. Cureus. 2021;13(12):e20194. Doi: 10.7759/cureus.20194 PubMed PMID: 35004016; PubMed Central PMCID: PMC8728626.[crossref] [PubMed]
41.
Majumdar T, Shete A, Yadav P, Patil S, Mali D, Waghmare A, et al. Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2021;108:226-30. Doi: 10.1016/j.ijid.2021.05.036 PubMed PMID: 34023493.[crossref] [PubMed]
42.
Yadav P, Dhankher S, Sharma S. Simplified visual detection of Kyasanur Forest Disease virus employing Reverse Transcriptase-Polymerase Spiral Reaction (RT-PSR). Virus Res. 2023;335:199180. Doi: 10.1016/j.virusres.2023.199180 PubMed PMID: 37482135; PubMed Central PMCID: PMC10412856.[crossref] [PubMed]
43.
Kumar JS, Yadav PD, Shete AM, Majumdar T, Patil S, Dash PK. Development and evaluation of reverse transcription loop-mediated isothermal amplification for rapid and real-time detection of Kyasanur forest disease virus. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2021;112:346-51. Doi: 10.1016/j.ijid.2021.01.041 PubMed PMID: 33486011.[crossref] [PubMed]
44.
Yadav P, Sharma S, Dash PK, Dhankher S, Sandhya V K, Kiran SK. Dry- down probe free qPCR for detection of KFD in resource limited settings. PloS One. 2023;18(5):e0284559. Doi: 10.1371/journal.pone.0284559 PubMed PMID: 37163557; PubMed Central PMCID: PMC10171661.[crossref] [PubMed]
45.
Parveen S, Riaz Z, Saeed S, Ishaque U, Sultana M, Faiz Z, et al. Dengue hemorrhagic fever: A growing global menace. J Water Health. 2023;21(11):1632-50. Doi: 10.2166/wh.2023.114 PubMed PMID: 38017595.[crossref] [PubMed]
46.
Rajapakse S, Fernando N, Dreyfus A, Smith C, Rodrigo C. Leptospirosis. Nat Rev Dis Primer. 2025;11(1):32. Doi: 10.1038/s41572-025-00614-5 PubMed PMID: 40316520.[crossref] [PubMed]
47.
Bohra B, Srivastava KS, Raj A, Pal N, Shukla R. Kyasanur Forest disease virus: Epidemiological insights, pathogenesis, therapeutic strategies, and advances in vaccines and diagnostics. Viruses. 2025;17(8):1022. Doi: 10.3390/v17081022 PubMed PMID: 40872737; PubMed Central PMCID: PMC12390728.[crossref] [PubMed]
48.
Molina-Cruz A, Zilversmit MM, Neafsey DE, Hartl DL, Barillas-Mury C. Mosquito vectors and the globalization of plasmodium falciparum malaria. Annu Rev Genet. 2016;50:447-65. Doi: 10.1146/annurev-genet-120215-035211 PubMed PMID: 27732796.[crossref] [PubMed]
49.
Rajaiah P. Kyasanur Forest Disease in India: Innovative options for intervention. Hum Vaccines Immunother. 2019;15(10):2243-48. Doi: 10.1080/21645515.2019.1602431 PubMed PMID: 30945970; PubMed Central PMCID: PMC6816375.[crossref] [PubMed]
50.
Oliveira A, Selvaraj K, Tripathy JP, Betodkar U, Cacodcar J, Wadkar A. Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India-A mixed methods operational research. PloS One. 2019;14(12):e0226141. Doi: 10.1371/journal.pone.0226141 PubMed PMID: 31891608; PubMed Central PMCID: PMC6938374.[crossref] [PubMed]
51.
Sidhik S, Santhosh S, Rathinam B. Knowledge, attitudes, and practices regarding ticks, tick-borne diseases, and ethnomedicine among an at-risk population in Kerala. Vector Borne Zoonotic Dis Larchmt N. 2024;24(2):86-94. Doi: 10.1089/vbz.2023.0040 PubMed PMID: 37844113.[crossref] [PubMed]
52.
Pattnaik S, Agrawal R, Murmu J, Kanungo S, Pati S. Does the rise in cases of Kyasanur forest disease call for the implementation of One Health in India? IJID Reg. 2023;7:18-21. Doi: 10.1016/j.ijregi.2023.02.003 PubMed PMID: 36941826; PubMed Central PMCID: PMC10024134.[crossref] [PubMed]
53.
Prejit, Hitziger M, Asha K. Effectiveness of one health approach for control of Kyasanur Forest Disease in Wayanad, Kerala, India. J Vector Borne Dis. 2022;59(1):70-78. Doi: 10.4103/0972-9062.331407 PubMed PMID: 35708407.[crossref] [PubMed]
54.
Burthe SJ, Schäfer SM, Asaaga FA, Balakrishnan N, Chanda MM, Darshan N, et al. Reviewing the ecological evidence base for management of emerging tropical zoonoses: Kyasanur Forest Disease in India as a case study. PLoS Negl Trop Dis. 2021;15(4):e0009243. Doi: 10.1371/journal.pntd.0009243 PubMed PMID: 33793560; PubMed Central PMCID: PMC8016103.[crossref] [PubMed]
55.
Mourya DT, Yadav PD, Patil DY, Sahay RR, Rahi M. Experiences of Indian Council of Medical Research with tick-borne zoonotic infections: Kyasanur Forest disease & Crimean-Congo haemorrhagic fever in India with One Health focus. Indian J Med Res. 2021;153(3):339-47. Doi: 10.4103/ijmr.IJMR_532_21 PubMed PMID: 33906997; PubMed Central PMCID: PMC8204825.[crossref] [PubMed]
56.
Keshavamurthy R, Charles LE. Predicting Kyasanur forest disease in resource-limited settings using event-based surveillance and transfer learning. Sci Rep. 2023;13(1):11067. Doi: 10.1038/s41598-023-38074-0 PubMed PMID: 37422454; PubMed Central PMCID: PMC10329696.[crossref] [PubMed]
57.
Hidalgo J, Richards GA, Jiménez JIS, Baker T, Amin P. Viral hemorrhagic fever in the tropics: Report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care. 2017;42:366-72. Doi: 10.1016/j.jcrc.2017.11.006 PubMed PMID: 29128377.[crossref] [PubMed]
58.
Rathinam B, Sidhik S. Species distribution and ecological suitability analysis for potential tick vectors of Kyasanur forest disease in the Western Ghats of Kerala. Med Vet Entomol. 2022;36(1):38-42. Doi: 10.1111/mve.12549 PubMed PMID: 34558682.[crossref] [PubMed]
59.
Boldescu V, Behnam MAM, Vasilakis N, Klein CD. Broad-spectrum agents for flaviviral infections: Dengue, Zika and beyond. Nat Rev Drug Discov. 2017;16(8):565-86. Doi: 10.1038/nrd.2017.33 PubMed PMID: 28473729; PubMed Central PMCID: PMC5925760.[crossref] [PubMed]
60.
Yadav PD, Gurav YK, Shete AM, Jain R, Nyayanit DA, Pardeshi PG, et al. Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease. Indian J Med Res. 2019;150(2):186-93. Doi: 10.4103/ijmr.IJMR_1929_17 PubMed PMID: 31670274; PubMed Central PMCID: PMC6829781.[crossref] [PubMed]
61.
Chattaraj S, Ganguly M, Chattaraj M, Mitra D, Kaibarta R, Ganguly A. Integrated approach for sustainable management and control of Kyasanur forest disease in alignment with sustainable development goals. Virology. 2026;614:110749. Doi: 10.1016/j.virol.2025.110749 PubMed PMID: 41297079.[crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2026/85541.24412

Date of Submission: Nov 24, 2025
Date of Peer Review: Feb 28, 2026
Date of Acceptance: Jun 17, 2026
Date of Publishing: Sep 01, 2026

Author declaration:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. No

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Nov 29, 2025
• Manual Googling: Jun 13, 2026
• iThenticate Software: Jun 15, 2026 (2%)

ETYMOLOGY: Author Origin

EMENDATIONS: 6

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com